financetom
Business
financetom
/
Business
/
Quanterix Q4 Net Loss Widens, Revenue Rises, 2025 Revenue Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quanterix Q4 Net Loss Widens, Revenue Rises, 2025 Revenue Outlook Set
Mar 17, 2025 2:03 PM

04:42 PM EDT, 03/17/2025 (MT Newswires) -- Quanterix ( QTRX ) late Monday reported a Q4 net loss of $0.30 per diluted share, wider than a $0.23 loss a year earlier.

One analyst polled by FactSet expected a $0.26 loss.

Revenue for the quarter ended Dec. 31 was $35.2 million, compared with $31.5 million a year earlier.

Analysts expected $34.5 million.

For 2025, the medical device company is expecting between $140.0 million to $146.0 million in revenue.

Analysts are looking for $155.1 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marvell Technology Insider Sold Shares Worth $2,075,400, According to a Recent SEC Filing
Marvell Technology Insider Sold Shares Worth $2,075,400, According to a Recent SEC Filing
May 17, 2024
03:23 AM EDT, 05/17/2024 (MT Newswires) -- Matthew J Murphy, Director, Chair of Board, President, Chief Executive Officer, on May 15, 2024, sold 30,000 shares in Marvell Technology ( MRVL ) for $2,075,400. Following the Form 4 filing with the SEC, Murphy has control over a total of 686,545 shares of the company, with 686,545 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1835632/000183563224000054/xslF345X03/wk-form4_1715899014.xml...
Exclusive-Musk pushes plan for China data to power Tesla's AI ambitions
Exclusive-Musk pushes plan for China data to power Tesla's AI ambitions
May 17, 2024
SHANGHAI/SINGAPORE (Reuters) - Tesla is pushing ahead with plans to power the global development of its self-driving system with data from China that could be processed within the country, part of a strategic shift by Elon Musk, according to people with knowledge of the work. As part of that effort, Tesla has been developing plans for a data center in...
Avidity Biosciences Insider Sold Shares Worth $2,121,045, According to a Recent SEC Filing
Avidity Biosciences Insider Sold Shares Worth $2,121,045, According to a Recent SEC Filing
May 17, 2024
03:24 AM EDT, 05/17/2024 (MT Newswires) -- Michael F MacLean, Chief Financial Officer, on May 14, 2024, sold 75,000 shares in Avidity Biosciences ( RNA ) for $2,121,045. Following the Form 4 filing with the SEC, MacLean has control over a total of 44,093 shares of the company, with 44,093 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1599901/000095017024061258/xslF345X03/ownership.xml Price: 29.40, Change: +0.68,...
Qorvo Insider Sold Shares Worth $2,214,514, According to a Recent SEC Filing
Qorvo Insider Sold Shares Worth $2,214,514, According to a Recent SEC Filing
May 17, 2024
03:26 AM EDT, 05/17/2024 (MT Newswires) -- Robert A Bruggeworth, Director, President and Chief Executive Officer, on May 14, 2024, sold 22,299 shares in Qorvo ( QRVO ) for $2,214,514. Following the Form 4 filing with the SEC, Bruggeworth has control over a total of 174,714 shares of the company, with 154,714 shares held directly and 20,000 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved